Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule. 2000

L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
Departments of Pathology, The Danish Cancer Society, Copenhagen, Denmark.

OBJECTIVE To evaluate the value of immunostaining using the monoclonal antibody (MoAB47) against thyroperoxidase (TPO) in distinguishing between benign and malignant tumour cells in fine needle aspiration cytology (FNAC) samples obtained from a solitary cold nodule of the thyroid gland for the purpose of strengthening the indication for thyroid surgery. METHODS A prospective, immunocytochemical study of FNACs taken from patients with solitary cold thyroid nodules who presented to Rigshospitalet, Copenhagen, Denmark, during the period April 1993 to May 1996. The first sample series was taken perioperatively in order to test the utility of the method. In the second part of the study samples were obtained preoperatively by ultrasonic guided aspiration. Tissue sections from the nodules obtained during a subsequent operation served as controls. METHODS One hundred and eighty-one patients, 150 women and 31 men, were studied. The age range was 14-89 years with a median age of 44 years. Fifty-seven patients were excluded from the study for various reasons leaving us with a total of 124 nodules from 124 patients for final evaluation. METHODS FNAC cells and corresponding nodular tissue were stained by immunocyto- and immuno-histochemistry using MoAb47 and by routine staining methods. Samples were considered benign if 80% or more of the epithelial-looking cells of both the FNACs and the histological tissue sections of the nodule were stained by TPO. Consequently, samples were considered malignant if more than 20% of the epithelial-looking cells failed to stain for TPO. Routinely stained tissue cells and sections served as diagnostic controls. RESULTS A pattern with negative TPO staining was found in all lesions which, by conventional histological staining, were subsequently proven to be malignant. A universal and reliable, positive TPO staining pattern was found in all subsequently proven benign lesions, with the exception of one out of 26 follicular adenomas. This gave the method a sensitivity of 1.0 (negative TPO staining = malignancy in 27 out of 27) and a specificity of 0.99 (positive TPO staining = benign lesion, in 96 out of 97). Positive and negative predictive values were 0.96 and 1.00 respectively. CONCLUSIONS Thyroperoxidase immunostaining of fine needle aspirates from solitary, scintigraphically cold nodules of the thyroid gland has proved to be an important and reliable diagnostic tool for distinguishing between benign and malignant nodules. Thus, patients might be spared further surgery if not otherwise indicated.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007453 Iodide Peroxidase A hemeprotein that catalyzes the oxidation of the iodide radical to iodine with the subsequent iodination of many organic compounds, particularly proteins. EC 1.11.1.8. Iodinase,Iodothyronine 5'-Deiodinase,Iodothyronine Deiodinase,Iodotyrosine Deiodase,Thyroid Peroxidase,Thyroxine 5'-Deiodinase,Thyroxine 5'-Monodeiodinase,5'-Deiodinase,Deiodinase,Iodotyrosine Deiodinase,Monodeiodinase,Reverse Triiodothyronine 5'-Deiodinase,T4-5'-Deiodinase,T4-Monodeiodinase,Tetraiodothyronine 5'-Deiodinase,Thyroxine Converting Enzyme,Triiodothyronine Deiodinase,5' Deiodinase,5'-Deiodinase, Iodothyronine,5'-Deiodinase, Reverse Triiodothyronine,5'-Deiodinase, Tetraiodothyronine,5'-Deiodinase, Thyroxine,5'-Monodeiodinase, Thyroxine,Deiodase, Iodotyrosine,Deiodinase, Iodothyronine,Deiodinase, Iodotyrosine,Deiodinase, Triiodothyronine,Enzyme, Thyroxine Converting,Iodothyronine 5' Deiodinase,Peroxidase, Iodide,Peroxidase, Thyroid,Reverse Triiodothyronine 5' Deiodinase,T4 5' Deiodinase,T4 Monodeiodinase,Tetraiodothyronine 5' Deiodinase,Thyroxine 5' Deiodinase,Thyroxine 5' Monodeiodinase,Triiodothyronine 5'-Deiodinase, Reverse
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004796 Clinical Enzyme Tests Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status. Enzyme Tests, Clinical,Clinical Enzyme Test,Enzyme Test, Clinical,Test, Clinical Enzyme,Tests, Clinical Enzyme
D005260 Female Females

Related Publications

L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
March 2000, Ugeskrift for laeger,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
September 1980, Indian journal of cancer,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
September 1972, Journal of the Medical Association of Georgia,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
April 2012, Mymensingh medical journal : MMJ,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
July 1981, Annals of the Academy of Medicine, Singapore,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
September 1984, Southern medical journal,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
January 1988, International surgery,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
April 1985, Archives francaises de pediatrie,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
November 1986, Postgraduate medical journal,
L Christensen, and M Blichert-Toft, and M Brandt, and M Lange, and S B Sneppen, and J Ravnsbaek, and C L Mollerup, and L Strange, and F Jensen, and J Kirkegaard, and H Sand Hansen, and S S Sørensen, and U Feldt-Rasmussen
April 1973, American journal of surgery,
Copied contents to your clipboard!